Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study

被引:223
|
作者
Battaglia, J [1 ]
Moss, S [1 ]
Rush, J [1 ]
Kang, J [1 ]
Mendoza, R [1 ]
Leedom, L [1 ]
Dubin, W [1 ]
McGlynn, C [1 ]
Goodman, L [1 ]
机构
[1] ALASKA PSYCHIAT INST,ANCHORAGE,AK
来源
AMERICAN JOURNAL OF EMERGENCY MEDICINE | 1997年 / 15卷 / 04期
关键词
haloperidol; lorazepam; psychotic agitation; rapid tranquilization;
D O I
10.1016/S0735-6757(97)90119-4
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rapid tranquilization is a routinely practiced method of calming agitated psychotic patients by use of neuroleptics, benzodiazepines, or both in combination, Although several studies have examined the efficacy of the three approaches, none have compared these treatments in a prospective, randomized, double-blind, multicenter trial. Ninety eight psychotic, agitated, and aggressive patients (73 men and 25 women) were prospectively enrolled during an 18-month period in emergency departments in five university or general hospitals. Patients were randomly assigned to receive intramuscular injections of lorazepam (2 mg), haloperidol (5 mg), or both in combination, Patients in each treatment group received 1 to 6 injections of the same study drug within 12 hours, based on clinical need, They were evaluated hourly after the first injection until at least 12 hours after the last. Efficacy was assessed on the Agitated Behavior Scale (ABS), a modified Brief Psychiatric Rating Scale (MBPRS), Clinical Global Impressions (CGI) scale, and an Alertness Scale. Effective symptom reduction was achieved in each treatment group with significant (P < .01) mean decreases from baseline at every hourly ABS evaluation. Significant (P < .05) mean differences on the ABS (hour 1) and MBPRS (hours 2 and 3) suggest that tranquilization was most rapid in patients receiving the combination treatment, Study event incidence (side effects) did not differ significantly between treatment groups, although patients receiving haloperidol alone tended to have more extrapyramidal system symptoms, The superior results produced by the combination treatment support the use of lorazepam plus haloperidol as the treatment of choice for acute psychotic agitation. (C) 1997 by W.B. Saunders Company.
引用
收藏
页码:335 / 340
页数:6
相关论文
共 50 条
  • [1] Prospective study of haloperidol plus lorazepam versus droperidol plus midazolam for the treatment of acute agitation in the emergency department
    Thiemann, Pauline
    Roy, David
    Huecker, Martin
    Senn, Joshua
    Javed, Jessica
    Thomas, Alyssa
    Shreffler, Jacob
    Shaw, Isaac
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2022, 55 : 76 - 81
  • [2] ZUCLOPENTHIXOL AND HALOPERIDOL IN PATIENTS WITH ACUTE PSYCHOTIC STATES - A DOUBLE-BLIND, MULTICENTER STUDY
    HEIKKILA, L
    ELIANDER, H
    VARTIAINEN, H
    TURUNEN, M
    PEDERSEN, V
    CURRENT MEDICAL RESEARCH AND OPINION, 1992, 12 (09) : 594 - 603
  • [3] Randomized Double-blind Trial of Intramuscular Droperidol, Ziprasidone, and Lorazepam for Acute Undifferentiated Agitation in the Emergency Department
    Martel, Marc L.
    Driver, Brian E.
    Miner, James R.
    Biros, Michelle H.
    Cole, Jon B.
    ACADEMIC EMERGENCY MEDICINE, 2021, 28 (04) : 421 - 434
  • [4] REMOXIPRIDE AND HALOPERIDOL IN SCHIZOPHRENIA - A DOUBLE-BLIND MULTICENTER STUDY
    AHLFORS, UG
    RIMON, R
    APPELBERG, B
    HAGERT, U
    HARMA, P
    KATILA, H
    MAHLANEN, A
    MEHTONEN, OP
    NAUKKARINEN, H
    OUTAKOSKI, J
    RANTANEN, H
    SORRI, A
    TAMMINEN, T
    TOLVANEN, E
    HOLM, AC
    ACTA PSYCHIATRICA SCANDINAVICA, 1990, 82 : 99 - 103
  • [5] A DOUBLE-BLIND COMPARATIVE MULTICENTER STUDY OF REMOXIPRIDE AND HALOPERIDOL IN SCHIZOPHRENIA
    ANDERSEN, J
    KORNER, A
    OSTERGAARD, P
    FENSBO, C
    BIRKETSMITH, M
    THIESEN, S
    HANSEN, NR
    FOGH, M
    KRISTENSEN, M
    MOLLERNIELSEN, EM
    JENSEN, B
    BJORUM, N
    ACTA PSYCHIATRICA SCANDINAVICA, 1990, 82 : 104 - 107
  • [6] A DOUBLE-BLIND COMPARATIVE MULTICENTER STUDY OF REMOXIPRIDE AND HALOPERIDOL IN SCHIZOPHRENIA
    LINDSTROM, LH
    WIESELGREN, IM
    STRUWE, G
    KRISTJANSSON, E
    AKSELSON, S
    ARTHUR, H
    ANDERSEN, T
    LINDGREN, S
    NORMAN, O
    NAIMELL, L
    STENING, G
    ACTA PSYCHIATRICA SCANDINAVICA, 1990, 82 : 130 - 135
  • [7] Ketamine Versus Haloperidol/Lorazepam/ Diphenhydramine Combination Treatment for Management of Acute Agitation in the Emergency Department
    Sunshine, Nicole
    Martinez, Jenny
    Bazan, Alexandra
    Wolowich, William R.
    Zitek, Tony
    OPEN ACCESS EMERGENCY MEDICINE, 2025, 17 : 113 - 120
  • [8] Intramuscular midazolam, olanzapine, or haloperidol for the management of acute agitation: A multi-centre, double-blind, randomised clinical trial
    Chan, Esther W.
    Lao, Kim S. J.
    Lam, Lam
    Tsui, Sik-Hon
    Lui, Chun-Tat
    Wong, Chi-Pang
    Graham, Colin A.
    Cheng, Chi-Hung
    Chung, Tong-Shun
    Lam, Hiu-Fung
    Ting, Soo-Moi
    Knott, Jonathan C.
    Taylor, David M.
    Kong, David C. M.
    Leung, Ling-Pong
    Wong, Ian C. K.
    ECLINICALMEDICINE, 2021, 32
  • [9] ZUCLOPENTHIXOL DECANOATE AND HALOPERIDOL DECANOATE IN CHRONIC-SCHIZOPHRENIA - A DOUBLE-BLIND MULTICENTER STUDY
    WISTEDT, B
    KOSKINEN, T
    THELANDER, S
    NERDRUM, T
    PEDERSEN, V
    MOLBJERG, C
    ACTA PSYCHIATRICA SCANDINAVICA, 1991, 84 (01) : 14 - 16
  • [10] A DOUBLE-BLIND MULTICENTER STUDY COMPARING REMOXIPRIDE, CONTROLLED RELEASE FORMULATION, WITH HALOPERIDOL IN SCHIZOPHRENIA
    PFLUG, B
    BARTELS, M
    BAUER, H
    BUNSE, J
    GALLHOFER, B
    HAAS, S
    KANZOW, WTH
    KLIESER, E
    KUFFERLE, B
    STEIN, D
    STEINBERGER, KA
    WEISELMANN, G
    ACTA PSYCHIATRICA SCANDINAVICA, 1990, 82 : 142 - 146